Mucosal immunization induces a higher level of lasting neutralizing antibody response in mice by a replication-competent smallpox vaccine: Vaccinia Tiantan strain

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  Chen, Zhiwei ^b,c   Lu, Bin ^a   Yu, Wenbo ^b   Huang, Xiaoxing ^a   Wang, Haibo ^b   Liu, Li ^b  

^a WUHAN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; SMALLPOX VACCINE; UNCLASSIFIED DRUG; VACCINIA VACCINE; VACCINIA VIRUS TIANTAN VACCINE; VIRUS SPIKE PROTEIN; LIVE VACCINE; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; IMMUNOGENICITY; MOUSE; NONHUMAN; SMALLPOX; VACCINATION; VACCINIA; VACCINIA VIRUS; VIRUS STRAIN; ANIMAL; BAGG ALBINO MOUSE; GENETICS; IMMUNIZATION; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MUCOSAL IMMUNITY; ORAL DRUG ADMINISTRATION; SMALLPOX VIRUS; SUBCUTANEOUS DRUG ADMINISTRATION;

MUS; VARIOLA VIRUS;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; FEMALE; IMMUNITY, MUCOSAL; IMMUNIZATION; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; MICE; MICE, INBRED BALB C; SMALLPOX; SMALLPOX VACCINE; VACCINATION; VACCINES, ATTENUATED; VACCINIA; VACCINIA VIRUS; VARIOLA VIRUS;

EID: 80052674064     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/970424     Document Type: Article

References (42)

1. Fulginiti V. A., Papier A., Lane J. M., Neff J. M., Henderson D. A., Smallpox vaccination: a review, part II. Adverse events Clinical Infectious Diseases 2003 37 2 251 271 (Pubitemid 36930357)
2. Nafziger S. D., Smallpox Critical Care Clinics 2005 21 4 739 746 (Pubitemid 41306215)
3. Henderson D. A., The eradication of smallpox Scientific American 1976 235 4 25 33
4. Sauri M. A., Frelinger J. A., Garba M. L., Belshe R. B., Frey S. E., Responses to smallpox vaccine The New England Journal of Medicine 2002 347 9 689 690
5. Heymann D. L., Smallpox containment updated: considerations for the 21st century International Journal of Infectious Diseases 2004 8 supplement 2 S15 S20
6. Amanna I. J., Messaoudi I., Slifka M. K., Protective immunity following vaccination: how is it defined? Human Vaccines 2008 4 4 316 319
7. Amanna I. J., Carlson N. E., Slifka M. K., Duration of humoral immunity to common viral and vaccine antigens The New England Journal of Medicine 2007 357 19 1903 1915 (Pubitemid 350074686)
8. Amanna I. J., Slifka M. K., Crotty S., Immunity and immunological memory following smallpox vaccination Immunological Reviews 2006 211 320 337 (Pubitemid 43882983)
9. Mahalingam S., Damon I. K., Lidbury B. A., 25 years since the eradication of smallpox: why poxvirus research is still relevant Trends in Immunology 2004 25 12 636 639 (Pubitemid 39457974)
10. Weltzin R., Liu J., Pugachev K. V., Clonal vaccinia virus grown in cell culture as a new smallpox vaccine Nature Medicine 2003 9 9 1125 1130 (Pubitemid 37173695)
11. Tang X., Chen Z., The development of an AIDS mucosal vaccine Viruses 2010 1 2 283 297
12. Fenner F., Henderson D. A., Arita I., Jezek Z., Ladnyi I. D., Smallpox and Its Eradication 1988 Geneva, Switzerland World Health Organization
13. Dong, Q. C. S. L., The founder of vaccinia virus Tiantan strain Weishengwuxue Mianyixue Jinzhan 2009 37 3 1 3
14. Yu W., Fang Q., Zhu W., One time intranasal vaccination with a modified vaccinia Tiantan strain MVTT(ZCI) protects animals against pathogenic viral challenge Vaccine 2010 28 9 2088 2096
15. Kretzschmar M., Wallinga J., Teunis P., Xing S., Mikolajczyk R., Frequency of adverse events after vaccination with different vaccinia strains PLoS Medicine 2006 3 8, article e272
16. Fang Q., Yang L., Zhu W., Host range, growth property, and virulence of the smallpox vaccine: vaccinia virus Tian Tan strain Virology 2005 335 2 242 251 (Pubitemid 40544913)
17. Huang X., Lu B., Yu W., A novel replication-competent vaccinia vector MVTT is superior to MVA for inducing high levels of neutralizing antibody via mucosal vaccination PLoS One 2009 4 1
18. Tscharke D. C., Reading P. C., Smith G. L., Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes Journal of General Virology 2002 83, part 8 1977 1986 (Pubitemid 34846459)
19. Liu H., Yu W., Tang X., The route of inoculation determines the tissue tropism of modified vaccinia Tiantan expressing the spike glycoprotein of SARS-CoV in mice Journal of Medical Virology 2010 82 5 727 734
20. Huang X., Liu L., Ren L., Qiu C., Wan Y., Xu J., Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses Vaccine 2007 25 52 8874 8884 (Pubitemid 350192050)
21. Joklik W. K., The purification of four strains of poxvirus Virology 1962 18 1 9 18
22. Chen Z., Zhang L., Qin C., Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region Journal of Virology 2005 79 5 2678 2688 (Pubitemid 40270546)
23. Tsai C., Caillet C., Hu H., Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase Vaccine 2009 27 48 6777 6790
24. Earl P. L., Americo J. L., Moss B., Development and use of a vaccinia virus neutralization assay based on flow cytometric detection of green fluorescent protein Journal of Virology 2003 77 19 10684 10688 (Pubitemid 37129714)
25. Benhnia M. R. E., McCausland M. M., Su H. P., Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine Journal of Virology 2008 82 7 3751 3768 (Pubitemid 351429950)
26. Edghill-Smith Y., Golding H., Manischewitz J., Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus Nature Medicine 2005 11 7 740 747 (Pubitemid 41021206)
27. Fazilleau N., Eisenbraun M. D., Malherbe L., Lymphoid reservoirs of antigen-specific memory T helper cells Nature Immunology 2007 8 7 753 761 (Pubitemid 46965351)
28. Neff J. M., Michael L. J., Fulginiti V. A., Henderson D. A., Contact vacciniatransmission of vaccinia from smallpox vaccination Journal of the American Medical Association 2002 288 15 1901 1905 (Pubitemid 35168147)
29. Robinson H. L., Montefiori D. C., Johnson R. P., Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations Nature Medicine 1999 5 5 526 534 (Pubitemid 29220211)
30. Snyder J. T., Belyakov I. M., Dzutsev A., Lemonnier F., Berzofsky J. A., Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses Journal of Virology 2004 78 13 7052 7060 (Pubitemid 38781543)
31. Kastenmuller W., Gasteiger G., Stross L., Busch D. H., Drexler I., Cutting edge: mucosal application of a lyophilized viral vector vaccine confers systemic and protective immunity toward intracellular pathogens Journal of Immunology 2009 182 5 2573 2577
32. Elst E., The transmission mechanism of smallpox rztliche Forschung 1955 9 1 13 32
33. Belyakov I. M., Isakov D., Zhu Q., Dzutsev A., Klinman D., Berzofsky J. A., Enhancement of CD8+ T cell immunity in the lung by CpG oligodeoxynucleotides increases protective efficacy of a modified vaccinia Ankara vaccine against lethal poxvirus infection even in a CD4-deficient host Journal of Immunology 2006 177 9 6336 6343 (Pubitemid 44628852)
34. Belyakov I. M., Earl P., Dzutsev A., Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses Proceedings of the National Academy of Sciences of the United States of America 2003 100 16 9458 9463 (Pubitemid 37033950)
35. Belyakov I. M., Moss B., Strober W., Berzofsky J. A., Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity Proceedings of the National Academy of Sciences of the United States of America 1999 96 8 4512 4517 (Pubitemid 29190367)
36. Naito T., Kaneko Y., Kozbor D., Oral vaccination with modified vaccinia virus Ankara attached covalently to TMPEG-modified cationic liposomes overcomes pre-existing poxvirus immunity from recombinant vaccinia immunization Journal of General Virology 2007 88, part 1 61 70 (Pubitemid 46085115)
37. Ranasinghe C., Medveczky J. C., Woltring D., Evaluation of fowlpox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1 Vaccine 2006 24 31-32 5881 5895 (Pubitemid 44173003)
38. Martinon F., Brochard P., Ripaux M., Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus Vaccine 2008 26 4 532 545
39. Goonetilleke N. P., McShane H., Hannan C. M., Anderson R. J., Brookes R. H., Hill A. V. S., Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara Journal of Immunology 2003 171 3 1602 1609 (Pubitemid 36900097)
40. Lu S., Heterologous prime-boost vaccination Current Opinion in Immunology 2009 21 3 346 351
41. Ba L., Yi C. E., Zhang L., Ho D. D., Chen Z., Heterologous MVA-S prime Ad5-S boost regimen induces high and persistent levels of neutralizing antibody response against SARS coronavirus Applied Microbiology and Biotechnology 2007 76 5 1131 1136 (Pubitemid 47415607)
42. Liu L., Zhong Q., Tian T., Dubin K., Athale S. K., Kupper T. S., Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity Nature Medicine 2010 16 2 224 227